Thursday, 15 October 202610:48 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

India

GLP-1 RAs and Metformin May Offer Different Clinical Benefits in antipsychotic-induced metabolic disturbances: Study

Image: Business Medical Dialogues. Rights remain with the publisher.

A new study published in the journal of BMC Medicine showed that GLP-1 receptor agonists and metformin could potentially provide distinct clinical advantages in managing metabolic complications...

Read the full report on Business Medical Dialogues

Story file

Section
India
First reported by
Business Medical Dialogues
Reporter
jacinthlyn sylvia
Published
Thursday, 15 October 2026, 9:15 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More India news

See all